Drug resistance mechanisms and novel drug targets for tuberculosis therapy-Reference-Cited by-同舟云学术

Drug resistance mechanisms and novel drug targets for tuberculosis therapy

Published:2017-01 Issue:1 Volume:44 Page:21-37
ISSN:1673-8527
Container-title:Journal of Genetics and Genomics
language:en
Short-container-title:Journal of Genetics and Genomics

Author:

Islam Md Mahmudul,Hameed H.M. Adnan,Mugweru Julius,Chhotaray Chiranjibi,Wang Changwei,Tan Yaoju,Liu Jianxiong,Li Xinjie,Tan Shouyong,Ojima Iwao,Yew Wing Wai,Nuermberger Eric,Lamichhane Gyanu^ORCID,Zhang Tianyu

Funder

National Natural Science Foundation of China

Chinese Academy of Sciences

State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Disease, First Allied Hospital of Guangzhou Medical University

Natural Science Foundation, Guangdong Province, China

Chinese Academy of Sciences-Commonwealth Scientific

Industrial Research Organization Mutual

Guangzhou Municipal Industry and Research Collaborative Innovation Program

Guangzhou Municipal Clinical Medical Center Program

CAS-TWAS

UCAS

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology

Reference278 articles.

1. Identification of novel imidazo [1, 2-a] pyridine inhibitors targeting M. tuberculosis QcrB;Abrahams;PLoS One,2012

2. Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India;Ajbani;J. Clin. Microbiol.,2011

3. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria;Alahari;PLoS One,2007

4. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis;Alangaden;Antimicrob. Agents Chemother.,1998

5. Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: a role for pncA but not rpsA;Alexander;J. Clin. Microbiol.,2012

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of antimycobacterial 8-hydroxyquinoline derivatives as in vitro enzymatic inhibitors of Mycobacterium tuberculosis enoyl-acyl carrier protein reductase;Bioorganic Chemistry;2024-10

2. Synchronization of Mycobacterium life cycle: A possible novel mechanism of antimycobacterial drug resistance evolution and its manipulation;Life Sciences;2024-06

3. Identification of Mutation Combinations in Genome-Wide Association Studies: Application for Mycobacterium tuberculosis;Pattern Recognition and Image Analysis;2024-06

4. In silico design, synthesis and antitubercular activity of novel 2-acylhydrazono-5-arylmethylene-4-thiazolidinones as enoyl-acyl carrier protein reductase inhibitors;Journal of Biomolecular Structure and Dynamics;2024-03-07

5. Drug-Resistant Tuberculosis: Development Mechanisms and Methods of Molecular Genetic Diagnosis;Annals of the Russian academy of medical sciences;2024-02-29